UniProt ID | MO4L2_HUMAN | |
---|---|---|
UniProt AC | Q15014 | |
Protein Name | Mortality factor 4-like protein 2 | |
Gene Name | MORF4L2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 288 | |
Subcellular Localization | Nucleus. | |
Protein Description | Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the MSIN3A complex which acts to repress transcription by deacetylation of nucleosomal histones.. | |
Protein Sequence | MSSRKQGSQPRGQQSAEEENFKKPTRSNMQRSKMRGASSGKKTAGPQQKNLEPALPGRWGGRSAENPPSGSVRKTRKNKQKTPGNGDGGSTSEAPQPPRKKRARADPTVESEEAFKNRMEVKVKIPEELKPWLVEDWDLVTRQKQLFQLPAKKNVDAILEEYANCKKSQGNVDNKEYAVNEVVAGIKEYFNVMLGTQLLYKFERPQYAEILLAHPDAPMSQVYGAPHLLRLFVRIGAMLAYTPLDEKSLALLLGYLHDFLKYLAKNSASLFTASDYKVASAEYHRKAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSRKQGSQ ------CCCCCCCCC | 38.56 | - | |
3 | Phosphorylation | -----MSSRKQGSQP -----CCCCCCCCCC | 42.05 | - | |
4 | Methylation | ----MSSRKQGSQPR ----CCCCCCCCCCC | 28.19 | 24384445 | |
8 | O-linked_Glycosylation | MSSRKQGSQPRGQQS CCCCCCCCCCCCCCC | 34.22 | 30379171 | |
11 | Methylation | RKQGSQPRGQQSAEE CCCCCCCCCCCCHHH | 48.17 | 24384453 | |
15 | Phosphorylation | SQPRGQQSAEEENFK CCCCCCCCHHHHHCC | 29.75 | 21815630 | |
22 | Methylation | SAEEENFKKPTRSNM CHHHHHCCCCCHHHH | 70.22 | 115973195 | |
22 | Ubiquitination | SAEEENFKKPTRSNM CHHHHHCCCCCHHHH | 70.22 | 33845483 | |
23 | Acetylation | AEEENFKKPTRSNMQ HHHHHCCCCCHHHHH | 47.70 | 23749302 | |
23 | Ubiquitination | AEEENFKKPTRSNMQ HHHHHCCCCCHHHHH | 47.70 | 29967540 | |
25 | Phosphorylation | EENFKKPTRSNMQRS HHHCCCCCHHHHHHH | 56.46 | 19413330 | |
35 | Methylation | NMQRSKMRGASSGKK HHHHHHHCCCCCCCC | 41.06 | 54557401 | |
42 | Ubiquitination | RGASSGKKTAGPQQK CCCCCCCCCCCCCCC | 47.32 | 24816145 | |
49 | Ubiquitination | KTAGPQQKNLEPALP CCCCCCCCCCCCCCC | 59.25 | 27667366 | |
63 | Phosphorylation | PGRWGGRSAENPPSG CCCCCCCCCCCCCCC | 43.12 | 26329039 | |
69 | Phosphorylation | RSAENPPSGSVRKTR CCCCCCCCCCCCCCC | 44.98 | 23401153 | |
71 | Phosphorylation | AENPPSGSVRKTRKN CCCCCCCCCCCCCCC | 24.08 | 23401153 | |
75 | Phosphorylation | PSGSVRKTRKNKQKT CCCCCCCCCCCCCCC | 35.99 | 28111955 | |
81 | Ubiquitination | KTRKNKQKTPGNGDG CCCCCCCCCCCCCCC | 59.29 | 24816145 | |
82 | Phosphorylation | TRKNKQKTPGNGDGG CCCCCCCCCCCCCCC | 33.65 | 21815630 | |
90 | Phosphorylation | PGNGDGGSTSEAPQP CCCCCCCCCCCCCCC | 34.00 | 25159151 | |
91 | Phosphorylation | GNGDGGSTSEAPQPP CCCCCCCCCCCCCCC | 33.58 | 22210691 | |
92 | Phosphorylation | NGDGGSTSEAPQPPR CCCCCCCCCCCCCCC | 33.20 | 28555341 | |
100 | Ubiquitination | EAPQPPRKKRARADP CCCCCCCCCCCCCCC | 53.00 | 29967540 | |
101 | Ubiquitination | APQPPRKKRARADPT CCCCCCCCCCCCCCC | 53.20 | 29967540 | |
116 | Ubiquitination | VESEEAFKNRMEVKV CCCHHHHHHCCEEEE | 51.17 | 33845483 | |
124 | Ubiquitination | NRMEVKVKIPEELKP HCCEEEEECCHHHHH | 46.99 | 33845483 | |
130 | Ubiquitination | VKIPEELKPWLVEDW EECCHHHHHHHHCCC | 37.11 | 29967540 | |
144 | Ubiquitination | WDLVTRQKQLFQLPA CCHHHHHHHHHCCCC | 45.75 | 29967540 | |
152 | Ubiquitination | QLFQLPAKKNVDAIL HHHCCCCCCCHHHHH | 42.83 | 29967540 | |
153 | Ubiquitination | LFQLPAKKNVDAILE HHCCCCCCCHHHHHH | 65.39 | 29967540 | |
166 | Ubiquitination | LEEYANCKKSQGNVD HHHHHCCCHHHCCCC | 56.09 | 32015554 | |
167 | Ubiquitination | EEYANCKKSQGNVDN HHHHCCCHHHCCCCC | 50.65 | 29967540 | |
175 | Ubiquitination | SQGNVDNKEYAVNEV HHCCCCCHHHHHHHH | 47.87 | 32015554 | |
238 | Sulfoxidation | LFVRIGAMLAYTPLD HHHHHHCHHHCCCCC | 1.53 | 28183972 | |
241 | Phosphorylation | RIGAMLAYTPLDEKS HHHCHHHCCCCCHHH | 12.62 | 19835603 | |
242 | Phosphorylation | IGAMLAYTPLDEKSL HHCHHHCCCCCHHHH | 16.27 | 19835603 | |
262 | Phosphorylation | YLHDFLKYLAKNSAS HHHHHHHHHHHCCCC | 17.65 | 19835603 | |
265 | Ubiquitination | DFLKYLAKNSASLFT HHHHHHHHCCCCCCC | 49.17 | 33845483 | |
267 | Phosphorylation | LKYLAKNSASLFTAS HHHHHHCCCCCCCCC | 20.66 | 21082442 | |
276 | Phosphorylation | SLFTASDYKVASAEY CCCCCCHHHHCCHHH | 12.60 | 22817900 | |
277 | Ubiquitination | LFTASDYKVASAEYH CCCCCHHHHCCHHHH | 35.99 | 22053931 | |
283 | Phosphorylation | YKVASAEYHRKAL-- HHHCCHHHHHHCC-- | 13.47 | 18083107 | |
286 | Ubiquitination | ASAEYHRKAL----- CCHHHHHHCC----- | 40.50 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MO4L2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MO4L2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MO4L2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND MASSSPECTROMETRY. |